In particular, we investigate whether molecular changes occur uniquely in response to pathogenic MBTPS2 variants causative of OI but not in response to variants causative of IFAP/KFSD, and whether these unique changes provide insights into mechanisms associated with skeletal dyshomeostasis. The gene discussed is MBTPS2; the disease is osteogenesis imperfecta.